Pharmaceutical Dosage Form Comprising Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone

Patent No. EP2305683 (titled "Pharmaceutical Dosage Form Comprising Oxycodone Hydrochloride Having Less Than 25 Ppm 14-Hydroxycodeinone") was filed by Euro Celtique on Mar 30, 2005. The application was issued on Sep 11, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOFFMANN EITLEOct 28, 2015HOFFMANN EITLE
SETNAOct 28, 2015BOULT WADE TENNANT
JAMES POOLEOct 27, 2015CARPMAELS & RANSFORD
ACINO PHARMA AGOct 26, 2015KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2305683

EURO CELTIQUE
Application Number
EP10011792A
Filing Date
Mar 30, 2005
Status
Patent Maintained As Amended
Aug 8, 2024
Publication Date
Sep 11, 2024